Janssen-Cilag Polskasp. z o.o.Active

Advertising agencies

KRS: 0000143626 NIP: 5222665719 REGON: 01529633900000

Overview

Registry date
2002-12-17
Share capital
$6,766,612.64
Activity description

Janssen-Cilag Polska is a pharmaceutical company that focuses on innovative medicine, particularly in oncology, immunology, and neuroscience. It has developed and received FDA approval for several treatments, including RYBREVANT FASPRO™ for EGFR-mutated non-small cell lung cancer, CAPLYTA® for major depressive disorder, and DARZALEX FASPRO® for high-risk smoldering multiple myeloma. The company also acquired Halda Therapeutics to enhance cancer treatment options.

Registered address
Iłżecka 24, 02-135 Warszawa, Poland
Website
janssen.plWebsite active
Electronic delivery address
AE:PL-98422-76133-RIAIU-27

Accounts

Registered as a VAT taxpayer on 2003-10-31.Active

Authorized Representatives

Ownership

Competitors

NameRevenueWebsite
Smollansp. z o.o.$31,314,517.86pmi.pl
Domodisp. z o.o.$12,618,800.86domodi.pl
Unique Onesp. z o.o.$10,199,051.53uniqueone.pl
Webtalksp. z o.o.$9,626,664.43webtalk.pl/
Blueranksp. z o.o.$9,076,272.51bluerank.pl
Feelgoodsp. z o.o.$8,945,125.90feelgood.pl
Fantasyexposp. z o.o.$8,746,133.20fantasyexpo.pl
Nairobiasp. z o.o.$8,380,325.13nairobia.pl
Bedigitalsp. z o.o.$8,128,445.76bedigital.pl
Goldenberry Groupsp. z o.o.$7,080,064.68goldenberry.com.pl

Change history

EventDetailsDate
Name changeJ-c Polska → Janssen-Cilag Polska2025-12-16
PKD changeRemoved: 72.30.Z, 73.10.F, 74.13.Z, 74.14.A, 74.40.Z, 74.84.B2025-12-16

FAQ

Last updated: 2026-07-09